Evenity Injection, Solution
Product Images NDC 55513-509
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Evenity (NDC 55513-509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B (Evenity 02)
Figure C (Evenity 03)
Figure D (Evenity 04)
Figure E (Evenity 05)
Figure A (Evenity 06)
Figure B (Evenity 07)
Figure C (Evenity 08)
Figure D (Evenity 09)
2 X 105 mg/1.17 mL Single-use Prefilled Syringe Ndc 55513-880-02 Evenity® (romosozumab-aqqg) Injection For Healthcare Provider Use Only 105 mg/1.17 mL + 105 mg/1.17 mL = 1 Dose 210 mg/2.34 mL 2 X 105 mg/1.17 mL 105 mg/1.17 mL For Subcutaneous Use Only Sterile Solution – No Preservative Store Refrigerated At 2°c To 8°c (36°f To 46°f). Do Not Freeze Or Shake. Store In Carton To Protect From Light. Keep Out Of The Sight And Reach Of Children. Attention: Provide The Enclosed Medication Guide To Each Patient. For More Copies See Evenity.com Or Call 1-800-77amgen. 2 Syringes Must Be Administered For A Full 210 mg/2.34 mL Dose Rx Only Amgen® Ucb (Evenity 10)
Principal Display Panel (105 mg/1.17 mL Syringe Carton)
Principal Display Panel (105 mg/1.17 mL Syringe Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.